RAC 3.31% $1.61 race oncology ltd

Medical / Clinical Discussions, page-206

  1. 15,728 Posts.
    lightbulb Created with Sketch. 1793
    IND was submitted last March! What we are waiting for is the approval by FDA after so long. Recent Israel trial results (just done in June) are the key to supplement this application, so we believe IND would be granted soon so we can start Phase 2 trial in USA for MRD. Very close now.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.